October 22, 2017 6:49 AM ET

Healthcare Providers and Services

Company Overview of Zellera AG

Company Overview

Zellera AG markets and distributes cell therapeutic products for stem cell tissue repair and the treatment of cancer and infectious diseases. The company’s products include AastromReplicell system and Cord Blood (CB)-I and CB-II therapy kits. Zellera is headquartered in Berlin, Germany. The company operates as a wholly owned subsidiary of Aastrom Biosciences, Inc.

Friedrichstrasse 50

Berlin,  10117

Germany

Phone:

49 30 20 65 91 65

Fax:

49 30 20 65 93 20

Key Executives for Zellera AG

Managing Director
Managing Director
Compensation as of Fiscal Year 2017.

Similar Private Companies By Industry

Company Name Region
4sigma GmbH Europe
Aac Praxisberatung Ag Europe
ACURA Kliniken Baden-Baden GmbH Europe
advita Pflegedienst GmbH Europe
AEP GmbH Europe

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
\
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
The Advertising Council, Inc. United States
NYC2012, Inc. United States
Tax Management Inc United States
Bertelsmann AG Europe

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Zellera AG, please visit www.zellera.de. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.